Smith & Nephew PLC on Wednesday backed its full-year outlook after growth in its Orthopaedics and Sports Medicine divisions offset weakness in Advanced Wound Management.
Shares in Smith & Nephew rose.
Smith & Nephew reported first-quarter revenue of $1.39bn in an update on Wednesday, up 2.9% year-on-year, as its orthopaedics business continued to recover.
Historic medical equipment manufacturing giant Smith+Nephew has reported growth in the first quarter and remains on track for a strong full-year performance.